Skip to content
Business Company News, Medical Health Aged Care

Professor Peter van Wijngaarden to become next Director and CEO of The Florey

The Florey 2 mins read

The Florey Board appoints new Director and CEO  

After an extensive global search, Professor Peter van Wijngaarden has been named as the next Director and CEO of The Florey Institute of Neuroscience and Mental Health. 

Board Chair Mr Martin Adams said Professor van Wijngaarden is an outstanding leader and an experienced clinician researcher who will take The Florey’s work to the world stage. 

“On behalf of the Board, I warmly welcome Peter to The Florey. As the largest brain research centre in the Southern Hemisphere, The Florey is home to remarkably talented people committed to advancing neuroscience and mental health research. Peter is exceptionally well-placed to take The Florey’s impact to the next level.” 

Professor van Wijngaarden said he was looking forward to taking up his new role next month. 

“I am honoured to be joining The Florey as its new Director and excited to be working with scientists who are leading the world in making fundamental discoveries in neuroscience and improving diagnostics and treatments for an impressive range of mental health and brain-related conditions,” Professor van Wijngaarden said.  

“The Florey has an incredible reputation and I look forward to building on that impressive legacy,” he said. 

Mr Adams thanked retiring Director Professor Trevor Kilpatrick for his leadership and commitment to the organisation.  

"Trevor has done an outstanding job leading The Florey through a period of important structural changes which have positioned us to continue to make significant scientific breakthroughs with our partners. I’m confident that Peter will build upon these efforts.”  

Professor Kilpatrick said he was proud to have served The Florey as its sixth Director. 

“I’m delighted that Professor van Wijngaarden has accepted this appointment,” Professor Kilpatrick said.  

“I have known Peter since his return from Cambridge where he undertook research in regenerative neuroscience with my long-term friend and colleague Professor Robin Franklin. 

“Since then, Peter has had a stellar career as a clinician scientist, administrator and entrepreneur. He is ideally placed to lead The Florey in the next phase of its journey as a world-leading neuroscience and mental health-oriented research institute.” 

Peter is Professor of Ophthalmology at the University of Melbourne and has served as Deputy Director at the Centre for Eye Research Australia (CERA). 

His research interests include retinal imaging, artificial intelligence, multiple sclerosis and Alzheimer’s disease. 

 


Key Facts:
  • Professor Peter van Wijngaarden has been selected to lead The Florey from 1 August 2024 

  • Professor van Wijngaarden is currently Deputy Director of the Centre for Eye Research Australia 


About us:

The Florey is Australia’s leading brain research institute with a focus on improving the lives of people with neurological and psychiatric conditions. The Florey’s research missions are centred around dementia, epilepsy, mental health and developing ways to protect and repair the brain. These missions are strengthened by The Florey’s expertise in neurotherapeutics, neuroimaging, synaptic biology and systems neuroscience. With 600 researchers, The Florey is the largest research centre of its kind in the southern hemisphere.

Find out more about us on our website: www.florey.edu.au


Contact details:

Kathryn Powley, Media and Communications Manager

kathryn.powley@florey.edu.au | 0456 666 271

Media

More from this category

  • Medical Health Aged Care
  • 23/10/2024
  • 14:43
Dementia Australia

Dementia Australia supports Bridgetown & Nannup

Are you concerned about your memory or worried that someone you know may have dementia? Dementia Australia is offering support in Bridgetown and Nannup between 6 and 8 November. It is estimated there are more than 40,500 people living with all forms of dementia in Western Australia. Without a medical breakthrough this number is expected to increase to almost 87,000 people living with dementia by 2054. These Dementia Australia sessions are an opportunity for people living with dementia, their carers, family, and friends to attend free education to better understand dementia and to discuss the support and services Dementia Australia…

  • Contains:
  • Building Construction, Business Company News
  • 23/10/2024
  • 09:28
Holcim Australia

Holcim Australia Unveils New Brand Identity

Holcim announces a new brand identity, aligning with its vision for sustainability and innovation Company is committed to delivering environmentally sustainable building solutions and…

  • Contains:
  • COVID19, Medical Health Aged Care
  • 23/10/2024
  • 08:55
PSS Distributors

Failed Vaccines Put Thousands of Aussie Lives at Risk and Cost the Government $22 Million in Wastage

The eye-watering cost of vaccine wastage and the serious public health threat posed by compromised vaccines already given to Australians are making headlines across major news outlets right now, underscoring the need for urgent action. The national press reported last week that over 1,200 patients at a general practice in Sydney’s inner west – including hundreds of children receiving their first vaccinations under the age of five –were informed that the vaccines they received between December 2019 and July 2024 may not be fully effective due to improper storage, leaving them prone to serious diseases like polio, hepatitis, meals, whooping…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.